Director Seoyeon Hyun is in charge of the overall clinical development of the company's pipeline based on her extensive work experience, from phase 1 - 3 clinical trials of domestic new drug development to global clinical trials of multinational pharmaceutical companies. She is a clinical development expert who recently led Australian TGA approval of a clinical trial for the company’s exosome treatment.

Starting with SK Chemicals, she has over 20 years of clinical development experience at global healthcare companies such as Boehringer Ingelheim, MSD and European Biotech and has served as a director role. Director Seoyeon Hyun received a bachelor's degree from Ewha Womans University's College of Pharmacy and a master's degree from Seoul National University's College of Pharmacy.